Genmab drug becomes more accessible in the US

Tepezza, which Genmab developed under the ownership of Horizon Therapeutics, has now entered the portfolio of products offered through the largest group of independent specialty pharmacies in the US.


Premier Pharmacy Services has now incorporated the Genmab-developed drug Tepezza in its product assortment, according to a press release from the pharmacy chain.

Premier Pharmacy Service is the largest independent specialty pharmacy company in the US, and it handles sales and distribution relating to particularly complicated pharmaceutical products such as Tepezza, an antibody treatment against the eye disease Graves ophthalmopathy.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs